NICE Guidance by month - July 2015

Reference Guidance Programme Topic
QS92 Smoking: harm reduction
Quality standards
MPG In development  Antimicrobial stewardship
Unclassified
Antibiotic use
STA In development  Macular oedema (diabetic) - aflibercept [ID717]
Technology appraisal guidance
Macular oedema and retinal vein occlusion
STA In development  Lung cancer (non-small cell) - nintedanib [ID438]
Technology appraisal guidance
Lung cancer
STA In development  Macular oedema (diabetic) - dexamethasone intravitreal implant [ID653]
Technology appraisal guidance
Macular oedema and retinal vein occlusion
STA In development  Secukinumab for treating moderate to severe plaque psoriasis [ID718]
Technology appraisal guidance
Psoriasis
STA In development  Organ rejection (liver transplantation, prevention) - everolimus [ID559]
Technology appraisal guidance
Liver conditions: general and other
QSD In development  Drug allergy - diagnosis and management
Quality standard
Blood and immune system conditions: general and other
QSD In development  Atrial fibrillation
Quality standard
Heart rhythm conditions
QSD In development  Obesity - prevention and lifestyle weight management in children
Quality standard
Diet, nutrition and obesity
STA In development  Constipation (opioid-induced) - naloxegol [ID674]
Technology appraisal guidance
Constipation
MT In development  The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites
Medical technology guidance
Healthcare-associated infections
QSD In development  Maternal and child nutrition - improving nutritional status
Quality standard
Infants and neonates
QSD In development  Bipolar disorder in adults
Quality standard
Bipolar disorder
QSD In development  Dyspepsia
Quality standard
Digestive tract conditions: general and other
CG In development  Melanoma
Guidelines
Skin cancer
Get involved